310 related articles for article (PubMed ID: 20855659)
1. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis.
Cruz-Adalia A; Jiménez-Borreguero LJ; Ramírez-Huesca M; Chico-Calero I; Barreiro O; López-Conesa E; Fresno M; Sánchez-Madrid F; Martín P
Circulation; 2010 Oct; 122(14):1396-404. PubMed ID: 20855659
[TBL] [Abstract][Full Text] [Related]
2. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
[TBL] [Abstract][Full Text] [Related]
3. Alterations in cardiac function and gene expression during autoimmune myocarditis in mice.
Stull LB; DiIulio NA; Yu M; McTiernan CF; Ratliff NB; Tuohy VK; Moravec CS
J Mol Cell Cardiol; 2000 Nov; 32(11):2035-49. PubMed ID: 11040107
[TBL] [Abstract][Full Text] [Related]
4. Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice.
Afanasyeva M; Georgakopoulos D; Fairweather D; Caturegli P; Kass DA; Rose NR
Circulation; 2004 Nov; 110(18):2910-7. PubMed ID: 15505106
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D
Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858
[TBL] [Abstract][Full Text] [Related]
6. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
[TBL] [Abstract][Full Text] [Related]
7. Quantification and characterization of myosin peptide-specific CD4+ T cells in autoimmune myocarditis.
Maier R; Miller S; Kurrer M; Krebs P; de Giuli R; Kremer M; Scandella E; Ludewig B
J Immunol Methods; 2005 Sep; 304(1-2):117-25. PubMed ID: 16125195
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody.
Gong X; Feng H; Zhang S; Yu Y; Li J; Wang J; Guo B
J Mol Cell Cardiol; 2007 Apr; 42(4):781-91. PubMed ID: 17362985
[TBL] [Abstract][Full Text] [Related]
9. Animal models for autoimmune myocarditis and autoimmune thyroiditis.
Ciháková D; Sharma RB; Fairweather D; Afanasyeva M; Rose NR
Methods Mol Med; 2004; 102():175-93. PubMed ID: 15286386
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice.
Liu W; Nakamura H; Shioji K; Tanito M; Oka S; Ahsan MK; Son A; Ishii Y; Kishimoto C; Yodoi J
Circulation; 2004 Sep; 110(10):1276-83. PubMed ID: 15337697
[TBL] [Abstract][Full Text] [Related]
11. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
[TBL] [Abstract][Full Text] [Related]
12. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis.
Kania G; Blyszczuk P; Valaperti A; Dieterle T; Leimenstoll B; Dirnhofer S; Zulewski H; Eriksson U
Cardiovasc Res; 2008 Nov; 80(2):236-45. PubMed ID: 18621802
[TBL] [Abstract][Full Text] [Related]
13. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
14. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis].
Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Guo SL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):751-6. PubMed ID: 22332535
[TBL] [Abstract][Full Text] [Related]
15. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
[TBL] [Abstract][Full Text] [Related]
16. Sulfated polysaccharide fucoidan ameliorates experimental autoimmune myocarditis in rats.
Tanaka K; Ito M; Kodama M; Tomita M; Kimura S; Hoyano M; Mitsuma W; Hirono S; Hanawa H; Aizawa Y
J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):79-86. PubMed ID: 21193680
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Sema4A in the progression of experimental autoimmune myocarditis.
Makino N; Toyofuku T; Takegahara N; Takamatsu H; Okuno T; Nakagawa Y; Kang S; Nojima S; Hori M; Kikutani H; Kumanogoh A
FEBS Lett; 2008 Nov; 582(28):3935-40. PubMed ID: 18977352
[TBL] [Abstract][Full Text] [Related]
18. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
[TBL] [Abstract][Full Text] [Related]
19. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis.
Pagni PP; Traub S; Demaria O; Chasson L; Alexopoulou L
Autoimmunity; 2010 Jun; 43(4):275-87. PubMed ID: 20187710
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
Blyszczuk P; Behnke S; Lüscher TF; Eriksson U; Kania G
Biochim Biophys Acta; 2013 Apr; 1833(4):934-44. PubMed ID: 23103516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
